Capital Research Global Investors
LLY icon

Capital Research Global Investors’s Eli Lilly LLY Stock Holding History

Capital Research Global Investors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25B Sell
20,873,140
-3,759,507
-15% -$3.84B 3.49% 5
2026
Q1 		$22.7B Buy
24,632,647
+65,801
+0.3% +$66.7M 3.51% 5
2025
Q4 		$26.4B Sell
24,566,846
-521,525
-2% -$499M 4.87% 4
2025
Q3 		$19.1B Buy
25,088,371
+4,332,008
+21% +$3.22B 3.59% 5
2025
Q2 		$16.2B Buy
20,756,363
+5,008,900
+32% +$3.89B 3.24% 6
2025
Q1 		$13B Buy
15,747,463
+4,989,952
+46% +$4.15B 2.83% 5
2024
Q4 		$8.3B Buy
10,757,511
+1,493,673
+16% +$1.24B 1.71% 10
2024
Q3 		$8.21B Buy
9,263,838
+144,304
+2% +$130M 1.71% 10
2024
Q2 		$8.26B Buy
9,119,534
+1,088,003
+14% +$870M 1.81% 11
2024
Q1 		$6.25B Buy
8,031,531
+453,939
+6% +$323M 1.41% 11
2023
Q4 		$4.42B Buy
7,577,592
+325,342
+4% +$190M 1.09% 20
2023
Q3 		$3.9B Buy
7,252,250
+469,273
+7% +$242M 1.07% 24
2023
Q2 		$3.18B Buy
6,782,977
+654,026
+11% +$274M 0.85% 27
2023
Q1 		$2.1B Buy
6,128,951
+1,037,933
+20% +$350M 0.6% 44
2022
Q4 		$1.86B Buy
5,091,018
+328,249
+7% +$116M 0.56% 50
2022
Q3 		$1.54B Buy
4,762,769
+1,848,662
+63% +$586M 0.51% 54
2022
Q2 		$945M Buy
+2,914,107
New +$875M 0.29% 80
2013
Q3 		– Sell
-800,000
Closed -$39.3M – 452
2013
Q2 		$39.3M Buy
+800,000
New +$43.5M 0.02% 343

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors's LLY Position: Q2 2026 in Review

Capital Research Global Investors reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $3.84B and leaving 20,873,140 shares worth $25B. The position accounts for 3.49% of the portfolio, ranked #5.

Capital Research Global Investors first reported a position in LLY in Q2 2013 and has held it in 18 quarters since. The position peaked at $26.4B in Q4 2025. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital Research Global Investors held 20,873,140 shares of Eli Lilly worth $25B as of Q2 2026.
  • Capital Research Global Investors sold 3,759,507 Eli Lilly shares in Q2 2026, an estimated $3.84B.
  • Eli Lilly made up 3.49% of Capital Research Global Investors's portfolio in Q2 2026, its #5 holding.
  • Capital Research Global Investors first reported a position in Eli Lilly in Q2 2013 and has held it in 18 quarters since.
  • Capital Research Global Investors's Eli Lilly position peaked at $26.4B in Q4 2025.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.